← Back to Patent Explorer
US3255191A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted 1, 3, 5-triazines

Assignee: Novartis Corp
•
Filing: 1964-04-21
•
Granted: 1966-06-07
•
Expires: 1984-04-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Dexter Martin
  • 👤 Knell Martin
  • 👤 Eric A Roskin

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 21:34
CPC Classifications
C; C08; C08K; C08K5/00; C08K5/16; C08K5/34; C08K5/3467; C08K5/3477; C08K5/3492; C08K5/36; C08K5/37; C08K5/378; C09; C09K; C09K15/00; C09K15/04; C09K15/30; C11; C11B; C11B5/00; C11B5/0071

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 4 words
COMPOUNDS OF THE FORMULA:
Claim 2
Dependent Claim 4 words
COMPOUNDS OF THE FORMULA:

References Cited (Backward Citations)

GB318275A Cited
US2481155A Cited
US2676150A Cited
US3043774A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1969-06-06 1969-12-06 1970-06-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1973-06-06 1973-12-06 1974-06-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1977-06-06 1977-12-06 1978-06-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag